The device is designed to serve as an alternative to the anticoagulants used to prevent thrombosis during surgery, so no 
drugs. The device looks to be a potentially safe alternative to medications to keep the blood thin, especially in view of recent news stories on this topic. BD
Medical device company MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL) said yesterday that three hospitals had ordered its second generation device for use in orthopedic surgery. The newest version of the company's device is designed to serve as an alternative to the anticoagulants used to prevent thrombosis during surgery, as opposed to its first product which was used in conjunction with medication. Because of the saving on medication it offers, Medical Compression will be able to market the latest version of its device at a higher price.
The ActiveCare® has received FDA and CE approvals and has also been authorized for marketing in Japan by Shonin (the Japanese Regulation Authority), as well as in Canada, Australia and Israel.
ActiveCare® has been FDA approved for:
Preventing Deep Vein Thrombosis (DVT) - Enhancing blood circulation
- Diminishing post- operative pain and swelling.
- Reduction wound- healing time.
- Treatment and assistance in healing: stasis dermatitis; venous stasis ulcers; arterial and diabetic leg ulcers.
- Treatment of chronic venous insufficiency.
- Reducing edema
Globes [online] - Israel business news - Three hospitals turn to MCS device instead of medication
The newly-published 2008 clinical guidelines for physicians from the American College of Chest Physicians (ACCP) on how to treat DVT and other forms of venous thromboembolic disease are available as a complimentary download at http://www.thenewguidelines.org
ReplyDeleteThank you Dennis for the link, we can always use updates from credible sources, believe me.
ReplyDelete